Response to comment on “Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity” and “Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination”

Comment on “Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity” and “Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination”

(2015) Scott B. Halstead   Science Translational Medicine

Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity

(2015) Naphak Modhiran et al.   Science Translational Medicine

Corticosteroids for Dengue – Why Don't They Work?

(2013) Thi Hanh Tien Nguyen et al.   PLoS Neglected Tropical Diseases

Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial

(2012) D. T. H. Tam et al.   CLINICAL INFECTIOUS DISEASES

RIG-I, MDA5 and TLR3 Synergistically Play an Important Role in Restriction of Dengue Virus Infection

(2011) A. M. A. Nasirudeen et al.   PLoS Neglected Tropical Diseases

Human TLR3 recognizes dengue virus and modulates viral replicationin vitro

(2008) Yi-Ting Tsai et al.   CELLULAR MICROBIOLOGY